2025 annual financial data
Verrica Pharmaceuticals 2025 Net income growth
Direct answer
Net income growth was 76.64%.
Operating income was -11,939,000 USD and net income was -17,886,000 USD.
Operating cash flow was -17,627,000 USD.
Get free Verrica Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 35,577,000 USD
- Operating income
- -11,939,000 USD
- Net income
- -17,886,000 USD
- Operating cash flow
- -17,627,000 USD